Clinical Trial Update: Neoadjuvant Immunochemotherapy for LAOSCC [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating neoadjuvant immunochemotherapy for locally advanced oral squamous cell carcinoma and head and neck squamous cell carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Oral Squamous Cell Carcinoma

Snippet

Sponsor: Lai-ping Zhong | Conditions: Oral Squamous Cell Carcinoma, Locally Advanced Head and Neck Carcinoma | Phase 3 | Status: RECRUITING